Lance Armstrong on doping: what the evidence says · JRE #737
“Did anybody that was on the tour ever drop dead from EPO? Well there's, there, there was, you know, look, there, there, I don't know, I mean there are a lot of documented cases especially in the 80s right when EPO I guess was first hitting the scene, there was this wave of Dutch cyclists that passed away in the night”
What the evidence says
Armstrong frames a wave of Dutch cyclists dying in their sleep as a "documented" 1980s consequence of early EPO use, calling it a hallmark case of the drug's dangers. This runs into a basic chronology problem: recombinant human EPO (Epogen) was not approved by the FDA for any clinical use until June 1989, and NIH-hosted historical accounts of the drug's development confirm it was not clinically available before then. That timeline makes it implausible that EPO doping was already widespread among cyclists earlier in the decade, undercutting Armstrong's framing of the deaths as an established "80s" EPO phenomenon. Notably, Armstrong's own phrasing hedges heavily -- "I don't know," "I didn't do the autopsy," "I don't know if anybody's ever proven that" -- which is itself an acknowledgment that the causal link was never medically confirmed, even as he calls the cases "documented."
- Information for Epogen/Procrit (Epoetin alfa) | FDA · government
- Anemia management: a historical perspective - PMC · government